Dihydrotestosterone levels at midpregnancy and term: a comparison with testosterone concentrations

Area of Science:

• Reproductive endocrinology
• Maternal-fetal medicine
• Androgen metabolism

Background:

• Dihydrotestosterone (DHT) is a potent androgen crucial for male sexual development.
• Understanding androgen dynamics during pregnancy is vital for assessing fetal well-being.
• Previous studies have indicated varying patterns for testosterone levels during gestation.

Purpose of the Study:

• To investigate the longitudinal changes in maternal and fetal plasma dihydrotestosterone (DHT) levels.
• To examine the concentration trends of DHT in amniotic fluid throughout pregnancy.
• To determine if sex differences exist in fetal DHT levels during gestation.

Main Methods:

• Collection of maternal plasma, fetal plasma, and amniotic fluid samples at different gestational stages (midpregnancy to term).
• Quantification of DHT levels using validated immunoassays or mass spectrometry.
• Statistical analysis to compare hormone levels across different time points and between sexes.

Main Results:

• Maternal plasma DHT levels showed no significant change from midpregnancy to term.
• Fetal plasma DHT levels remained constant throughout the observed gestational period.
• A significant 75% increase in DHT concentrations was observed in amniotic fluid from midpregnancy to term.
• No statistically significant sex differences were detected in either fetal plasma or amniotic fluid DHT levels.

Conclusions:

• Amniotic fluid serves as a dynamic reservoir for dihydrotestosterone, with increasing levels towards term.
• Fetal and maternal plasma DHT levels appear to be tightly regulated during the latter half of pregnancy.
• The absence of sex differences in fetal DHT contrasts with findings for testosterone, suggesting distinct regulatory mechanisms or metabolic pathways.